Lung Cancer

A research study to determine whether an investigational medication has an effect as a 2nd-line treatment in non-small cell lung cancer ("NSCLC") for patients having failed one prior platinum-containing chemotherapy regimen. Volunteers at least 18 who have had one previous treatment of a platinum-based drug such as cisplatin or carboplatin may be eligible. Research sites located throughout the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat34.html.